Friday, July 10, 2026
🇺🇸 FDA

pharma · Mantle Cell Lymphoma · Colon cancer

Telethon Foundation

Fondazione Telethon ETS

Telethon Foundation clinical programs — 162 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
roma, IT HQ
1990 Founded
343 Employees
EMA registrant Type
Company details
Status
Public
HQ
roma, IT
Founded
1990
Employees
343
Programs
162
Drugs
285
Patents
0
Official website ↗ All projects Drug pipeline News & analysis
Intelligence · Clinical Programs

Telethon Foundation projects

162 ClinicalTrials.gov programs sponsored by Telethon Foundation.

Telethon Foundation has 162 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

162 programs

Clinical programs

Page 1 of 4

  1. ALL2820

    Fondazione Telethon ETS

    Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.

    phase 3 small molecule active

    1 trial

  2. Abraxane /ml powder for dispersion for infusion. for metastatic NSCLC patients

    Fondazione Telethon ETS

    metastatic NSCLC patients

    phase 3 small molecule active

    1 trial

  3. BEVACIZUMAB, ERLOTINIB

    Fondazione Telethon ETS

    Non-squamous Non-small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  4. Beyfortus solution for Respiratory Syncytial Virus (RS…

    Fondazione Telethon ETS

    Respiratory Syncytial Virus (RSV)

    phase 3 small molecule active

    1 trial

  5. CAPECITABINE for Locally advanced stage II/III rectal cancer

    Fondazione Telethon ETS

    Locally advanced stage II/III rectal cancer

    phase 3 small molecule active

    1 trial

  6. COLECALCIFEROL , PREDNISONE

    Fondazione Telethon ETS

    Elderly patients with Diffuse Large B-Cell Lymphoma (DLBCL)

    phase 3 small molecule active

    1 trial

  7. D3 (Penta 21)

    Fondazione Telethon ETS

    HIV-infected

    phase 3 small molecule active

    1 trial

  8. DAUNORUBICIN for Favorable-intermediate-risk Acu…

    Fondazione Telethon ETS

    Favorable-intermediate-risk Acute Myeloid Leukemia

    phase 3 small molecule active

    1 trial

  9. EMN20

    Fondazione Telethon ETS

    PATIENTS WITH NEW DIAGNOSIS MULTIPLE MYELOMA WITH AGE >= 65 YEARS OR NOT ELIGIBLE TO ASCT

    phase 3 small molecule active

    1 trial

  10. FIL_FOLL19

    Fondazione Telethon ETS

    Follicular Lymphoma

    phase 3 small molecule active

    1 trial

  11. FIL_Renoir12

    Fondazione Telethon ETS

    Follicular lymphoma

    phase 3 small molecule active

    1 trial

  12. FM-17-B01

    Fondazione Telethon ETS

    Invasive Breast Cancer

    phase 3 small molecule active

    1 trial

  13. GIMEMA AML1919

    Fondazione Telethon ETS

    Acute Myeloid Leukemia (LMA) with FLT3 mutation

    phase 3 small molecule active

    1 trial

  14. IFOM-CPT0092022PO008

    Fondazione Telethon ETS

    Colon cancer

    phase 3 small molecule active

    1 trial

  15. Levotiroxina Teva 25 microgrammi compresse

    Fondazione Telethon ETS

    Hodgkin and non Hodgkin lymphoma, Medulloblastoma

    phase 3 small molecule active

    1 trial

  16. Lynparza film-coated tablets for Recurrent ovarian cancer

    Fondazione Telethon ETS

    Recurrent ovarian cancer

    phase 3 small molecule active

    1 trial

  17. MDS0519

    Fondazione Telethon ETS

    Higher-risk-myelodysplastic syndromes

    phase 3 small molecule active

    1 trial

  18. MITO 33

    Fondazione Telethon ETS

    Recurrent ovarian, fallopian tube or primary peritoneal cancer

    phase 3 small molecule active

    1 trial

  19. Neuraceq 300 MBq/mL solution for injection

    Fondazione Telethon ETS

    cardiac amyloidosis

    phase 3 small molecule active

    1 trial

  20. OTL-103, OTL-103

    Fondazione Telethon ETS

    Wiskott-Aldrich syndrome (WAS)

    phase 3 small molecule active

    1 trial

  21. OTL-103-4

    Fondazione Telethon ETS

    Wiskott-Aldrich Syndrome

    phase 3 small molecule active

    1 trial

  22. PREDNISONE for Idiopathic IgA nephropathy (IgAN)

    Fondazione Telethon ETS

    Idiopathic IgA nephropathy (IgAN)

    phase 3 small molecule active

    1 trial

  23. REFINE_2020

    Fondazione Telethon ETS

    Generalized Myasthenia Gravis

    phase 3 small molecule active

    1 trial

  24. The placebo product consists of a soft capsul...

    Fondazione Telethon ETS

    Prevention of recurrence after a first episode of Venous Thromboembolism (VTE)

    phase 3 small molecule active

    1 trial

  25. Tora-Dol /ml soluzione iniettabile for Patients scheduled for major su…

    Fondazione Telethon ETS

    Patients scheduled for major surgery for oncologic indication

    phase 3 small molecule active

    1 trial

  26. Vectibix 20 mg/ml concentrate for solution for infusion

    Fondazione Telethon ETS

    Unresectable left sided RAS/B-RAF wild-type metastatic colorectal cancer

    phase 3 small molecule active

    1 trial

  27. 18FMC225_FPG

    Fondazione Telethon ETS

    depression

    phase 2 small molecule active

    1 trial

  28. A study of niraparib in combination with abem... for Ovarian cancer

    Fondazione Telethon ETS

    Ovarian cancer

    phase 2 other active

    1 trial

  29. ABEMACICLIB , RO7197597

    Fondazione Telethon ETS

    ER-positive, HER2-negative Early breast cancer

    phase 2 small molecule active

    1 trial

  30. AECOPD

    Fondazione Telethon ETS

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule active

    1 trial

  31. AIRC Id. 21939

    Fondazione Telethon ETS

    Metastatic DTC

    phase 2 small molecule active

    1 trial

  32. ALL2418

    Fondazione Telethon ETS

    Acute B-cell Lymphoblastic Leukemia with minimal residual positive disease prior to haematopoietic stem cell transplantation in adult patients

    phase 2 small molecule active

    1 trial

  33. ALL2620

    Fondazione Telethon ETS

    Ph+ Acute Lymphoblastic Leukemia

    phase 2 small molecule active

    1 trial

  34. ALL3024

    Fondazione Telethon ETS

    Very High-Risk T-Lineage Acute Lymphoblastic Leukemia (ALL)

    phase 2 small molecule active

    1 trial

  35. AML1718

    Fondazione Telethon ETS

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  36. AML2420

    Fondazione Telethon ETS

    Acute Myeloid Leukemia secondary to myeloproliferative neoplasms

    phase 2 small molecule active

    1 trial

  37. AML2521

    Fondazione Telethon ETS

    Acute Myeloid Leukemia with NPM1 mutation

    phase 2 small molecule active

    1 trial

  38. AVELUMAB, Erbitux 5 mg/mL solution for infusion

    Fondazione Telethon ETS

    recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC)

    phase 2 small molecule active

    1 trial

  39. Acido Acetilsalicilico Teva Italia compresse...

    Fondazione Telethon ETS

    Patients scheduled for major surgery for oncologic indication

    phase 2 small molecule active

    1 trial

  40. Avastin /ml concentrate for Advanced non-small-cell lung ca…

    Fondazione Telethon ETS

    Advanced non-small-cell lung cancer

    phase 2 small molecule active

    1 trial

  41. Avastin /ml concentrate for Patients with ras-mutated metas…

    Fondazione Telethon ETS

    Patients with ras-mutated metastatIc colorectal cancer

    phase 2 small molecule active

    1 trial

  42. BCG-RIS-01

    Fondazione Telethon ETS

    RIS (Radiologically Isolated Syndrome)

    phase 2 small molecule active

    1 trial

  43. BLEOMYCIN

    Fondazione Telethon ETS

    colorectal cancer

    phase 2 small molecule active

    1 trial

  44. BLEOMYCIN, CISPLATIN

    Fondazione Telethon ETS

    patients with newly diagnosed or recurrent high-grade or initially invasive precancerous squamous lesions of the vulva and non-invasive vulvar Paget's disease

    phase 2 small molecule active

    1 trial

  45. BLEOPRIM for CARCINOMA OF THE ORAL CAVITY AN…

    Fondazione Telethon ETS

    CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX

    phase 2 small molecule active

    1 trial

  46. BLEOPRIM for Locally Advanced Pancreatic Can…

    Fondazione Telethon ETS

    Locally Advanced Pancreatic Cancer

    phase 2 small molecule active

    1 trial

  47. Bactrim + compresse for Chronic Lymphocytic Leukemia

    Fondazione Telethon ETS

    Chronic Lymphocytic Leukemia

    phase 2 small molecule active

    1 trial

  48. Busulfan Koanaa /ml Konzentrat zur Herstellun...

    Fondazione Telethon ETS

    transfusion-dependent beta-thalassemia

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Telethon Foundation have?

162 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.